Tiens Biotech Group (USA) Reports Second Quarter and Six-Mon...( NEW YORK Aug. 14 /Xinhua-- Tiens ...)

NEW YORK, Aug. 14 /Xinhua-PRNewswire/ -- Tiens Biotech Group (USA), Inc. (the "Company" or "Tiens", AMEX: TBV), http://www.tiens-bio.com , announced financial results for the second quarter and six months ended June 30, 2008.

For the second quarter ended June 30, 2008, revenue was $19.7 million, an increase of 37.2% compared to $14.3 million for the same period in 2007.

Net income for the second quarter of 2008 was $4.6 million, compared to net income of $5.0 million for the second quarter of 2007. Earnings per share for the second quarter of each of 2008 and 2007 were $0.07.

For the six months ended June 30, 2008, revenue was $32.5 million, an increase of 6.3% compared to $30.6 million for the same period in 2007.

Net income for the six months ended June 30, 2008 was $8.3 million, compared to net income of $11.5 million for the first six months of 2007. Earnings per share for six months ended June 30, 2008 were $0.12 compared to $0.16 for the first six months of 2007.

The significant growth in revenue during the second quarter of 2008 includes an increase in both domestic and international revenue for the period. Revenue in China increased 65.6% to $8.5 million, compared to $5.1 million for the second quarter of 2007, reflecting successful marketing efforts in China and the increase in the value of the renminbi against the dollar. In addition, international revenue rose 21.4% to $11.1 million for the second quarter, compared to $9.2 million for the same period in 2007, reflecting a reduction on export restrictions in that period by China's Administration of Quality Supervision, Inspection and Quarantine ("AQSIQ") which announced an ongoing national campaign in China against unsafe food and substandard products in August 2007. It is important to note that to date, no problems have been identified with any of Tiens' products.

Results for the six months ended June 30,
'/>"/>